Descriptor English: | Cinnarizine | ||||
Descriptor Spanish: |
Cinarizina
| ||||
Descriptor Portuguese: | Cinarizina | ||||
Descriptor French: | Cinnarizine | ||||
Entry term(s): |
1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine Cinarizina Inkey Cinarizina Ratiopharm Cinarizine Cinazière Cinna Cinnarizin AL Cinnarizin Ratiopharm Cinnarizin Siegfried Cinnarizin Von Ct Cinnarizin-Ratiopharm Cinnarizine L Tartrate Cinnarizine L-Tartrate Cinnarizine L-Tartrate (1:1) Cinnarizine, (E)-Isomer Cinnarizine, Dihydrochloride Cinnipirine Cisaken Dihydrochloride Cinnarizine Dimitronal L-Tartrate, Cinnarizine R 516 R-516 R516 Stugeron Stugeron Forte Von Ct, Cinnarizin |
||||
Tree number(s): |
D03.383.606.290 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D002936 | ||||
Scope note: | A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Calcium Channel Blockers Histamine H1 Antagonists |
||||
Registry Number: | 3DI2E1X18L | ||||
CAS Type 1 Name: | Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)- | ||||
Previous Indexing: |
Cinnamates (1971-1974) Piperazines (1968-1974) |
||||
Public MeSH Note: | 86; see PIPERAZINES 1975-85 |
||||
History Note: | 86(75) |
||||
DeCS ID: | 2963 | ||||
Unique ID: | D002936 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1986/01/01 | ||||
Date of Entry: | 1974/11/19 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Cinnarizine
- Preferred
Cinarizina Ratiopharm
- Narrower
Cinazière
- Narrower
Cinna
- Narrower
Cinnarizin AL
- Narrower
Cinnarizin Siegfried
- Narrower
Cinnarizine L-Tartrate
- Narrower
Cinnarizine L-Tartrate (1:1)
- Narrower
Cinnarizine, (E)-Isomer
- Narrower
Cinnarizine, Dihydrochloride
- Narrower
Cinnipirine
- Narrower
Cisaken
- Narrower
Dimitronal
- Narrower
R-516
- Narrower
Stugeron
- Narrower
Cinarizina Inkey
- Narrower
Concept UI |
M0004492 |
Scope note | A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS. |
Preferred term | Cinnarizine |
Entry term(s) |
1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine Cinarizine |
Concept UI |
M0478428 |
Preferred term | Cinarizina Ratiopharm |
Entry term(s) |
Cinnarizin Ratiopharm Cinnarizin-Ratiopharm |
Concept UI |
M0478426 |
Preferred term | Cinazière |
Concept UI |
M0478425 |
Preferred term | Cinna |
Entry term(s) |
Cinnarizin Von Ct Von Ct, Cinnarizin |
Concept UI |
M0478429 |
Preferred term | Cinnarizin AL |
Concept UI |
M0478430 |
Preferred term | Cinnarizin Siegfried |
Concept UI |
M0331354 |
Preferred term | Cinnarizine L-Tartrate |
Entry term(s) |
Cinnarizine L Tartrate L-Tartrate, Cinnarizine |
Concept UI |
M0331356 |
Preferred term | Cinnarizine L-Tartrate (1:1) |
Concept UI |
M0331353 |
Preferred term | Cinnarizine, (E)-Isomer |
Concept UI |
M0331355 |
Preferred term | Cinnarizine, Dihydrochloride |
Entry term(s) |
Dihydrochloride Cinnarizine |
Concept UI |
M0478424 |
Preferred term | Cinnipirine |
Concept UI |
M0478423 |
Preferred term | Cisaken |
Concept UI |
M0004493 |
Preferred term | Dimitronal |
Concept UI |
M0353364 |
Preferred term | R-516 |
Entry term(s) |
R 516 R516 |
Concept UI |
M0004494 |
Preferred term | Stugeron |
Entry term(s) |
Stugeron Forte |
Concept UI |
M0478427 |
Preferred term | Cinarizina Inkey |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey